{
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "document": "CDC_Influenza_vaccines",
  "verification_stats": {
    "total_extracted": 1,
    "verified": 0,
    "rejected": 1,
    "verification_rate": 0.0
  },
  "verified_evidence": [],
  "rejected_evidence": [
    {
      "id": 1,
      "quote": "Flublok Quadrivalent (Sanofi Pasteur) 0.5 mL PFS \u226518 yrs 45 \u00b5g/0.5 mL IM ... RIV4 (recombinant HA vaccine)",
      "reason": "does not support claim",
      "original_explanation": "This quote identifies Flublok as a recombinant HA vaccine (RIV4), which means it is produced using recombinant technology. This method allows for the production of hemagglutinin antigens that are an exact genetic match to the WHO- and FDA-selected flu strains, supporting the claim of identical antigenic match."
    }
  ],
  "model_used": "gpt-4.1"
}